• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention describes the use of the intracellular content of mesenchymal stem cells in individuals to stimulate the survival, regeneration and/or repair of the damaged organ and/or tissue. In addition, the present invention also describes the use of this lysate for the preparation of a pharmaceutical composition comprising said intracellular content, and its use in the regeneration and/or repair of the damaged organ and/or tissue. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2573354A1
    申请号:ES201431630
    申请日:2014-11-06
    公开日:2016-06-07
    发明作者:Juan Rafael MUÑOZ CASTAÑEDA；Juan Manuel DÍAZ TOCADOS；Juan Manuel DOMÍNGUEZ PÉREZ
    申请人:Universidad de Cordoba；Servicio Andaluz de Salud；
    IPC主号:
    专利说明:

    image 1
    image2
    image3
    image4
    image5
    image6
    image7
    image8
    image9
    image10
    image11
    image12
    image13
    image14
    image15
    image16
    image17
    image18
    image19
    image20
    image21
    image22
    image23
    image24
    image25
    image26
    image27
    权利要求:
    Claims (1)
    [1]
    image 1
    image2
    类似技术:
    公开号 | 公开日 | 专利标题
    CO2017004525A2|2017-08-10|Ror-gamma inhibitory dihydropyrrolopyridines
    DOP2017000109A|2017-07-31|DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL AND ITS USES
    BR112017009497A2|2018-02-06|aadc polynucleotides for the treatment of parkinson's disease
    CL2015003731A1|2016-07-29|Bromodomain Inhibitors
    CO2019013707A2|2020-04-01|Aadc polynucleotides for the treatment of parkinson's disease
    CL2014001752A1|2014-10-10|Substituted bicyclic compounds; pharmaceutical composition that includes them; and use in the treatment of diseases such as cancer, Alzheimer's, AIDS, among others.
    BR112015022191A2|2017-10-10|heteroaryl compounds, their use and composition comprising them
    CL2016003214A1|2017-06-23|Indolizine derivatives as phosphoinositide-3 kinase inhibitors
    CL2016001918A1|2017-01-13|Heteroaryl amides as protein aggregation inhibitors
    EA202090683A3|2020-09-30|METHODS AND COMPOSITIONS FOR CANCER TREATMENT
    CL2016002422A1|2017-02-03|Chromen and 1, 1a, 2,7b-tetrahydrocyclopropa [c] chromene pyridopyrazinadiones as modulators of gamma-secretases.
    CL2016000026A1|2016-08-12|New azabenzimidazole derivatives
    BR112015032526A2|2017-07-25|anti-dandruff compositions and methods of use thereof
    ECSP16086247A|2017-02-24| -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
    CO2020015156A2|2021-02-26|Rip1 Inhibitor Compounds and Methods for Making and Using The Same Cross Reference to a Related Application
    CO2017001601A2|2017-07-28|1-Acetyl-4 - | amino) -1,2,3,4-tetrahydroquinoline-6 carboxamide derivatives as bromodomain inhibitors
    DOP2017000014A|2017-06-30|METHODS TO IMPROVE MIOCARDIC PERFORMANCE IN PATIENTS WITH FONTAN SURGERY USING UDENAFILO COMPOSITIONS
    DOP2016000297A|2016-12-30|PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES
    DK3016666T3|2019-07-01|Fish oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and / or preventing Alzheimer's disease
    MX2018014129A|2019-04-29|Pharmaceutical composition comprising eteplirsen.
    CR20150653A|2016-03-04|NEW COMPOUNDS FOR CANCER TREATMENT
    CL2015001881A1|2015-11-06|Compound 4-hydroxy-2-methyl-5- | cyclohexyl-3-en-1-carbaldehyde; use of the compound for the treatment of Alzheimer's disease; pharmaceutical composition; Method to prepare the composition.
    ES2573354A1|2016-06-07|Lysates of mesenchymal stem cells for the treatment of musculoskeletal injuries |
    IT201600081379A1|2018-02-03|Pharmaceutical composition for use in the treatment of prostatic diseases.
    ES2536842T3|2015-05-29|Pharmaceutical composition for cancer treatment
    同族专利:
    公开号 | 公开日
    EP3216860A1|2017-09-13|
    ES2573354B1|2017-03-24|
    CA2966975A1|2016-05-12|
    US20170340673A1|2017-11-30|
    AU2015341657A1|2017-06-01|
    EP3216860A4|2018-07-04|
    EP3216860B1|2021-08-11|
    WO2016071555A1|2016-05-12|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    PL2578081T3|2006-10-11|2016-09-30|Compositions, methods, and devices for treating liver disease|
    WO2009065093A2|2007-11-17|2009-05-22|University Of Medicine And Dentistry Of New Jersey|Use of stem cells for wound healing|
    EP2279246A4|2008-05-02|2012-03-28|Massachusetts Inst Technology|Methods and compositions for modulating immunological tolerance|CN108126187A|2018-01-19|2018-06-08|深圳光彩生命工程技术有限公司|A kind of composition and preparation method|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    ES201431630A|ES2573354B1|2014-11-06|2014-11-06|Lysenchymal stem cell lysates for the treatment of skeletal muscle lesions|ES201431630A| ES2573354B1|2014-11-06|2014-11-06|Lysenchymal stem cell lysates for the treatment of skeletal muscle lesions|
    CA2966975A| CA2966975A1|2014-11-06|2015-11-06|Lysates of mesenchymal stem cells for the treatment of skeletal muscle injuries|
    US15/524,957| US20170340673A1|2014-11-06|2015-11-06|Lysates of mesenchymal stem cells for the treatment of skeletal muscle injuries|
    PCT/ES2015/070797| WO2016071555A1|2014-11-06|2015-11-06|Lysates of mesenchymal stem cells for the treatment of skeletal muscle injuries|
    AU2015341657A| AU2015341657A1|2014-11-06|2015-11-06|Lysates of mesenchymal stem cells for the treatment of skeletal muscle injuries|
    EP15857509.2A| EP3216860B1|2014-11-06|2015-11-06|Lysates of mesenchymal stem cells for the treatment of skeletal muscle injuries|
    [返回顶部]